NCT06356662View on ClinicalTrials.gov

Tenofovir Disoproxil Fumarate in the Treatment of Parkinson's Disease

PHASE1RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 23, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Parkinson Disease
Interventions
DRUG

Tenofovir Disoproxil Fumarate

take tenofovir disoproxil fumarate 300mg/d

Trial Locations (1)

Unknown

RECRUITING

Guohua Zhao, Hangzhou

All Listed Sponsors
lead

The Fourth Affiliated Hospital of Zhejiang University School of Medicine

OTHER